Related Experiment Video
Updated: May 15, 2026

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
Published on: September 6, 2017
The DQ barrier: improving organ allocation equity using HLA-DQ information
Anat R Tambur1, Joseph R Leventhal, Jennifer R Zitzner
1Transplant Immunology Laboratory, Comprehensive Transplant Center, Feinberg School of Medicine, Northwestern University, 303 E. Chicago Avenue, Tarry Building Suite 11-711, Chicago, IL 60611-3008, USA. a-tambur@northwestern.edu
Considering human leukocyte antigen (HLA)-DQα/β combinations improves kidney transplant crossmatch accuracy. This approach allows patients with specific HLA-DQ antibodies to proceed with crossmatch, enhancing organ allocation equity.
Area of Science:
- Immunogenetics
- Transplantation immunology
- Molecular biology
Background:
- Current kidney allocation algorithms primarily use HLA-A, -B, and -DR loci.
- HLA-DQ unacceptable antigen assignment overlooks the polymorphic DQα chain, impacting antibody recognition.
Observation:
- Patients with HLA-DQ antibodies were analyzed for crossmatch (XM) outcomes.
- High-resolution HLA typing identified specific DQα/β allele combinations.
Findings:
- 24% of patients with HLA-DQ antibodies had negative flow XM due to allelic DQα/β mismatches.
- Virtual XM incorporating DQα/β combinations accurately predicted over 98% of XM results.
Implications:
- Excluding patients based on serologic HLA-DQ antigens may hinder transplant opportunities.
- Integrating DQα/β allele information can enhance virtual XM accuracy and promote equitable organ allocation.
Related Concept Videos
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Kidney Transplant I: Introduction

